Biotechs investigate mitochondria-targeting drugs to claim a share in the weight loss drug market dominated by GLP-1RAs.

Corcept Therapeutics' Q2 2025 earnings call highlights relacorilant's transformative potential in hypercortisolism and oncology, with $3-5B ...

In analysis of 5268 women from the first childbirth, the proportion of treated women began to decline 18 months before childbirth.

Only strains backed by at least two randomised controlled trials are recommended, highlighting the need for evidence-based probiotic use in children.

CrazyBulk announces safest SARMs for bulking, cutting, and strength in 2025, offering an alternative to traditional anabolic steroids.Glassgow, Aug. 01, 2025 (GLOBE NEWSWIRE) -- CrazyBulk, a ...